Global Cardiac Biomarkers Market to Reach $28 Billion by 2030
The global market for Cardiac Biomarkers estimated at US$15.7 Billion in the year 2022, is projected to reach a revised size of US$28 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2022-2030. Troponins (T & I), one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$11.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Brain Natriuretic Peptide (BNPs) or NT-proBNP segment is readjusted to a revised 7.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 12.2% CAGR
The Cardiac Biomarkers market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.9 Billion by the year 2030.Select Competitors (Total 39 Featured) -
- Abbott Diagnostics
- Beckman Coulter Inc.
- BG Medicine
- bioMérieux SA
- Boditech Med Inc.
- Labsystems Diagnostics OY
- LifeSign LLC
- LSI Medience Corp.
- Merck KGaA
- Ortho-Clinical Diagnostics Inc.
- Quidel Corporation
- Randox Laboratories
- Response Biomedical Corp.
- Roche Diagnostics Corp.
- Siemens Healthineers
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Beckman Coulter Inc.
- BG Medicine
- bioMérieux SA
- Boditech Med Inc.
- Labsystems Diagnostics OY
- LifeSign LLC
- LSI Medience Corp.
- Merck KGaA
- Ortho-Clinical Diagnostics Inc.
- Quidel Corporation
- Randox Laboratories
- Response Biomedical Corp.
- Roche Diagnostics Corp.
- Siemens Healthineers
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 272 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 15.7 Billion |
Forecasted Market Value ( USD | $ 28 Billion |
Compound Annual Growth Rate | 7.5% |
Regions Covered | Global |